Circulating markers of inflammation are related to carotid artery atherosclerosis

P T Larsson1, S Hallerstam, S Rosfors

  • 1Department of Clinical Physiology, Karolinska Institute at Södersjukhuset, Stockholm, Sweden. thomas.larsson@sodersjukhuset.se

Insights

Inflammation markers like IL-6 are linked to carotid artery atherosclerosis in patients with coronary artery disease. Interleukin-6 (IL-6) appears to be a key independent biomarker for this condition.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Biomarker Discovery

Background:

  • Inflammation plays a critical role in atherothrombotic disorders.
  • Understanding the link between inflammatory markers and atherosclerosis is crucial for disease management.

Purpose of the Study:

  • To prospectively investigate the relationships between inflammatory markers, hemostatic variables, and non-invasive measures of carotid artery atherosclerosis.
  • To identify potential biomarkers for atherosclerosis in patients with coronary artery disease (CAD).

Main Methods:

  • Assessed hemostasis markers (sP-selectin, fibrinogen), cytokines (IL-6, IL-8, TNF-a, MCP-1), inflammatory variables (hsCRP, SAA, calprotectin), and cell adhesion molecules (ICAM-1, VCAM-1).
  • Utilized ultrasonography to measure carotid artery atherosclerosis in 111 outpatients with manifest or suspected CAD.

Main Results:

  • Higher IL-6 levels were observed in patients with manifest cardiovascular disease and carotid plaques.
  • Increased carotid artery lumen diameter and intima-media area correlated with elevated levels of IL-6, IL-8, MCP-1, hsCRP, calprotectin, sP-selectin, fibrinogen, and VCAM-1.
  • Interleukin-6 (IL-6) demonstrated a significant independent association with lumen diameter after adjusting for multiple risk factors.

Conclusions:

  • Multiple inflammatory biomarkers are associated with ultrasonographic measures of carotid artery atherosclerosis in patients with moderate to high CAD prevalence.
  • Interleukin-6 (IL-6) is identified as a potentially independent and valuable biomarker for atherosclerosis in this patient cohort.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...